COVID-19
infectie na immunisatie
||
aandoening door infectie met 'Severe acute respiratory syndrome'-coronavirus 2 na vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 (aandoening)
COVID-19 na vaccinatie tegen SARS-CoV-2
aandoening door infectie met 'Severe acute respiratory syndrome'-coronavirus 2 na vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2
COVID-19 na toediening van vaccin tegen SARS-CoV-2
aandoening door infectie met SARS-CoV-2 na vaccinatie tegen SARS-CoV-2
aandoening door infectie met SARS-coronavirus 2 na actieve immunisatie tegen SARS-coronavirus 2
SARS-CoV-2 breakthrough infection
Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2
COVID-19 breakthrough infection
Severe acute respiratory syndrome coronavirus 2 breakthrough infection
Id1217296006
StatusDefined
Aftervaccinatie tegen SARS-CoV-2
Causative agentSARS-CoV-2
Pathological processinfectieus proces
SNOMED CT to ICD-10 extended map
TargetT88.0
RuleTRUE
AdviceALWAYS T88.0 | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE
CorrelationSNOMED CT source code to target map code correlation not specified
TargetU07.1
RuleTRUE
AdviceALWAYS U07.1 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified